AG真人官方

STOCK TITAN

[8-K] Dyadic International, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Dyadic International (NASDAQ:DYAI) filed an 8-K disclosing receipt of a Nasdaq Listing Rule 5550(b)(2) deficiency notice for failing to maintain the minimum $35 million Market Value of Listed Securities (MVLS).

The stock has been below the threshold for 30 consecutive business days, activating a 180-day cure period ending December 20, 2025. To regain compliance, DYAI鈥檚 MVLS must close at or above $35 million for at least 10 consecutive trading days before the deadline. Failure would prompt a delisting determination, which the company could appeal, though success is not assured.

The notice has no immediate effect on Nasdaq trading but flags heightened liquidity and financing risk. Management says it will monitor MVLS and 鈥渆valuate available options,鈥� yet outlines no specific actions. Forward-looking statements reiterate ongoing losses, capital needs, and potential breaches of other listing standards, underscoring uncertainty for shareholders.

Dyadic International (NASDAQ:DYAI) ha presentato un modulo 8-K comunicando di aver ricevuto un avviso di carenza ai sensi della Regola di Quotazione Nasdaq 5550(b)(2) per non aver mantenuto il valore minimo di 35 milioni di dollari di Market Value of Listed Securities (MVLS).

Il titolo 猫 rimasto al di sotto della soglia per 30 giorni lavorativi consecutivi, attivando un periodo di recupero di 180 giorni che scade il 20 dicembre 2025. Per tornare in regola, il MVLS di DYAI deve chiudere a o sopra i 35 milioni di dollari per almeno 10 giorni di negoziazione consecutivi prima della scadenza. In caso contrario, si proceder脿 con una delisting, che la societ脿 potr脿 impugnare, anche se senza garanzia di successo.

尝鈥檃惫惫颈蝉辞 non ha effetto immediato sulle negoziazioni Nasdaq, ma segnala un rischio aumentato di liquidit脿 e finanziamento. Il management dichiara che monitorer脿 il MVLS e "valuter脿 le opzioni disponibili", senza per貌 indicare azioni specifiche. Le dichiarazioni prospettiche ribadiscono perdite in corso, necessit脿 di capitale e possibili violazioni di altri standard di quotazione, evidenziando incertezza per gli azionisti.

Dyadic International (NASDAQ:DYAI) present贸 un formulario 8-K informando sobre la recepci贸n de un aviso de deficiencia seg煤n la Regla de Listado Nasdaq 5550(b)(2) por no mantener el valor m铆nimo de 35 millones de d贸lares en Market Value of Listed Securities (MVLS).

La acci贸n ha estado por debajo del umbral durante 30 d铆as h谩biles consecutivos, activando un per铆odo de correcci贸n de 180 d铆as que finaliza el 20 de diciembre de 2025. Para recuperar el cumplimiento, el MVLS de DYAI debe cerrar en o por encima de 35 millones de d贸lares durante al menos 10 d铆as de negociaci贸n consecutivos antes de la fecha l铆mite. De no hacerlo, se iniciar谩 un proceso de exclusi贸n que la compa帽铆a podr谩 apelar, aunque sin garant铆a de 茅xito.

El aviso no tiene efecto inmediato en la negociaci贸n en Nasdaq, pero se帽ala un mayor riesgo de liquidez y financiamiento. La direcci贸n indica que supervisar谩 el MVLS y "evaluar谩 las opciones disponibles", sin detallar acciones espec铆ficas. Las declaraciones prospectivas reiteran p茅rdidas continuas, necesidades de capital y posibles incumplimientos de otros est谩ndares de listado, subrayando la incertidumbre para los accionistas.

Dyadic International (NASDAQ:DYAI)电� 雮橃姢雼� 靸侅灔 攴滌箼 5550(b)(2) 瓴绊暔 韱奠靹�毳� 靾橂牴頄堧嫟瓿� 8-K 氤搓碃靹滊ゼ 鞝滌稖頄堨姷雼堧嫟. 鞚吹鐢 斓滌唽 3,500毵� 雼煬鞚� 靸侅灔 歃濌秾 鞁滌灔 臧旃�(MVLS)毳� 鞙犾頃橃 氇豁枅旮� 霑岆鞛呺媹雼�.

欤检嫕鞚 30瓯半灅鞚� 鞐办啀 旮办 鞚错晿搿� 毹鸽霟� 2025雲� 12鞗� 20鞚检棎 膦呺霅樀鐢 180鞚检潣 臧滌劆 旮瓣皠鞚� 鞁滌瀾霅橃棃鞀惦媹雼�. 攴滌爼 欷靾橂ゼ 須岆车頃橂牑氅� DYAI鞚� MVLS臧 毵堦皭 鞁滌爯鞐� 斓滌唽 3,500毵� 雼煬 鞚挫儊鞚挫柎鞎� 頃橂┌, 鞚� 臁瓣贝鞚� 毵堦皭鞚� 鞝勳棎 鞐办啀 10瓯半灅鞚� 霃欖晥 於╈”頃挫暭 頃╇媹雼�. 鞁ろ尐頃� 瓴届毎 靸侅灔 韽愳 瓴办爼鞚� 雮措牑歆� 靾� 鞛堨溂氅�, 須岇偓电� 鞚挫潣毳� 鞝滉赴頃� 靾� 鞛堨溂雮� 靹标车鞚� 氤挫灔霅橃电� 鞎婌姷雼堧嫟.

韱奠电� 歃夑皝鞝侅澑 雮橃姢雼� 瓯半灅 欷戨嫧 須臣电� 鞐嗢毵�, 鞙犽彊靹标臣 鞛愱笀 臁半嫭 鞙勴棙鞚� 歃濌皜頄堨潓鞚� 鞎岆雼堧嫟. 瓴届榿歆勳潃 MVLS毳� 氇媹韯半頃橁碃 "臧電ロ暅 鞓奠厴鞚� 韽夑皜頃� 瓴�"鞚措澕瓿� 氚濏様鞙茧倶 甑泊鞝侅澑 臁办箻电� 鞝滌嫓頃橃 鞎婌晿鞀惦媹雼�. 氙鸽灅 鞓堨浮 歆勳垹鞐愳劀电� 歆靻嶌爜鞚� 靻愳嫟, 鞛愲掣 頃勳殧靹�, 旮绊儉 靸侅灔 旮办 鞙勲皹 臧電レ劚鞚� 鞛皑 鞏戈笁頃橂┌ 欤检<霌れ棎瓴� 攵堩檿鞁れ劚鞚� 臧曥“頃╇媹雼�.

Dyadic International (NASDAQ:DYAI) a d茅pos茅 un rapport 8-K r茅v茅lant la r茅ception d鈥檜n avis de carence selon la r猫gle de cotation Nasdaq 5550(b)(2) pour ne pas avoir maintenu la valeur minimale de 35 millions de dollars en Market Value of Listed Securities (MVLS).

Le titre est rest茅 en dessous du seuil pendant 30 jours ouvrables cons茅cutifs, d茅clenchant une p茅riode de correction de 180 jours se terminant le 20 d茅cembre 2025. Pour retrouver la conformit茅, le MVLS de DYAI doit cl么turer 脿 ou au-dessus de 35 millions de dollars pendant au moins 10 jours de bourse cons茅cutifs avant la date limite. En cas d鈥櫭ヽhec, une d茅cision de radiation sera prise, que la soci茅t茅 pourra contester, bien que sans garantie de succ猫s.

尝鈥檃惫颈蝉 n鈥檃 pas d鈥檈ffet imm茅diat sur les 茅changes Nasdaq mais signale un risque accru de liquidit茅 et de financement. La direction indique qu鈥檈lle surveillera le MVLS et 芦 茅valuera les options disponibles 禄, sans pr茅ciser d鈥檃ctions sp茅cifiques. Les d茅clarations prospectives r茅it猫rent les pertes en cours, les besoins en capital et les violations potentielles d鈥檃utres normes de cotation, soulignant l鈥檌ncertitude pour les actionnaires.

Dyadic International (NASDAQ:DYAI) hat einen 8-K-Bericht eingereicht, in dem der Erhalt einer Nasdaq-Listing-Regel 5550(b)(2) M盲ngelmitteilung wegen Nichterf眉llung des Mindestwertes von 35 Millionen US-Dollar Market Value of Listed Securities (MVLS) offengelegt wird.

Die Aktie lag 30 aufeinanderfolgende Handelstage unter dem Schwellenwert, wodurch eine 180-t盲gige Nachfrist bis zum 20. Dezember 2025 in Kraft tritt. Um die Compliance wiederherzustellen, muss der MVLS von DYAI an mindestens 10 aufeinanderfolgenden Handelstagen vor Ablauf der Frist bei oder 眉ber 35 Millionen US-Dollar schlie脽en. Andernfalls wird eine Delisting-Entscheidung eingeleitet, gegen die das Unternehmen Berufung einlegen kann, wobei ein Erfolg nicht garantiert ist.

Die Mitteilung hat keine unmittelbaren Auswirkungen auf den Nasdaq-Handel, weist jedoch auf erh枚hte Risiken bei Liquidit盲t und Finanzierung hin. Das Management erkl盲rt, dass es den MVLS 眉berwachen und "verf眉gbare Optionen evaluieren" wird, nennt jedoch keine konkreten Ma脽nahmen. Prognostische Aussagen betonen weiterhin laufende Verluste, Kapitalbedarf und m枚gliche Verst枚脽e gegen andere Listing-Standards, was Unsicherheit f眉r die Aktion盲re unterstreicht.

Positive
  • None.
Negative
  • Nasdaq deficiency notice received for MVLS below $35 million, creating immediate compliance pressure.
  • Only 180 days to restore market value, with potential delisting if unsuccessful.
  • Management disclosed no specific remediation plan, raising dilution and capital-access concerns.

Insights

TL;DR: Delisting threat pressures valuation and funding options.

The MVLS breach places DYAI on a six-month clock to add roughly $10-15 million to market cap, assuming a current value near $20-25 million. Options include equity raises, strategic transactions, or price-support tactics, each carrying dilution or execution risk. Until compliance is regained, institutional ownership screens tied to Nasdaq status could constrain liquidity. Historically, companies missing MVLS often struggle to reverse sentiment without fundamental catalysts; absence of a clear plan amplifies uncertainty. The disclosure therefore tilts risk-reward sharply negative for near-term investors.

TL;DR: Listing-rule breach signals governance stress and potential OTC migration.

The deficiency notice is material because continued Nasdaq listing underpins shareholder protections, analyst coverage, and capital-raising efficiency. DYAI now faces enhanced scrutiny from regulators and investors, especially given prior net losses and low bid-price buffer. Failure to cure by December 20 would move the stock toward a hearings process with an uncertain outcome and likely additional costs. Even if an appeal buys time, protracted non-compliance often erodes investor confidence. Without a concrete remediation roadmap鈥攔everse split, asset sale, or strategic partner鈥攖he governance optics remain negative.

Dyadic International (NASDAQ:DYAI) ha presentato un modulo 8-K comunicando di aver ricevuto un avviso di carenza ai sensi della Regola di Quotazione Nasdaq 5550(b)(2) per non aver mantenuto il valore minimo di 35 milioni di dollari di Market Value of Listed Securities (MVLS).

Il titolo 猫 rimasto al di sotto della soglia per 30 giorni lavorativi consecutivi, attivando un periodo di recupero di 180 giorni che scade il 20 dicembre 2025. Per tornare in regola, il MVLS di DYAI deve chiudere a o sopra i 35 milioni di dollari per almeno 10 giorni di negoziazione consecutivi prima della scadenza. In caso contrario, si proceder脿 con una delisting, che la societ脿 potr脿 impugnare, anche se senza garanzia di successo.

尝鈥檃惫惫颈蝉辞 non ha effetto immediato sulle negoziazioni Nasdaq, ma segnala un rischio aumentato di liquidit脿 e finanziamento. Il management dichiara che monitorer脿 il MVLS e "valuter脿 le opzioni disponibili", senza per貌 indicare azioni specifiche. Le dichiarazioni prospettiche ribadiscono perdite in corso, necessit脿 di capitale e possibili violazioni di altri standard di quotazione, evidenziando incertezza per gli azionisti.

Dyadic International (NASDAQ:DYAI) present贸 un formulario 8-K informando sobre la recepci贸n de un aviso de deficiencia seg煤n la Regla de Listado Nasdaq 5550(b)(2) por no mantener el valor m铆nimo de 35 millones de d贸lares en Market Value of Listed Securities (MVLS).

La acci贸n ha estado por debajo del umbral durante 30 d铆as h谩biles consecutivos, activando un per铆odo de correcci贸n de 180 d铆as que finaliza el 20 de diciembre de 2025. Para recuperar el cumplimiento, el MVLS de DYAI debe cerrar en o por encima de 35 millones de d贸lares durante al menos 10 d铆as de negociaci贸n consecutivos antes de la fecha l铆mite. De no hacerlo, se iniciar谩 un proceso de exclusi贸n que la compa帽铆a podr谩 apelar, aunque sin garant铆a de 茅xito.

El aviso no tiene efecto inmediato en la negociaci贸n en Nasdaq, pero se帽ala un mayor riesgo de liquidez y financiamiento. La direcci贸n indica que supervisar谩 el MVLS y "evaluar谩 las opciones disponibles", sin detallar acciones espec铆ficas. Las declaraciones prospectivas reiteran p茅rdidas continuas, necesidades de capital y posibles incumplimientos de otros est谩ndares de listado, subrayando la incertidumbre para los accionistas.

Dyadic International (NASDAQ:DYAI)电� 雮橃姢雼� 靸侅灔 攴滌箼 5550(b)(2) 瓴绊暔 韱奠靹�毳� 靾橂牴頄堧嫟瓿� 8-K 氤搓碃靹滊ゼ 鞝滌稖頄堨姷雼堧嫟. 鞚吹鐢 斓滌唽 3,500毵� 雼煬鞚� 靸侅灔 歃濌秾 鞁滌灔 臧旃�(MVLS)毳� 鞙犾頃橃 氇豁枅旮� 霑岆鞛呺媹雼�.

欤检嫕鞚 30瓯半灅鞚� 鞐办啀 旮办 鞚错晿搿� 毹鸽霟� 2025雲� 12鞗� 20鞚检棎 膦呺霅樀鐢 180鞚检潣 臧滌劆 旮瓣皠鞚� 鞁滌瀾霅橃棃鞀惦媹雼�. 攴滌爼 欷靾橂ゼ 須岆车頃橂牑氅� DYAI鞚� MVLS臧 毵堦皭 鞁滌爯鞐� 斓滌唽 3,500毵� 雼煬 鞚挫儊鞚挫柎鞎� 頃橂┌, 鞚� 臁瓣贝鞚� 毵堦皭鞚� 鞝勳棎 鞐办啀 10瓯半灅鞚� 霃欖晥 於╈”頃挫暭 頃╇媹雼�. 鞁ろ尐頃� 瓴届毎 靸侅灔 韽愳 瓴办爼鞚� 雮措牑歆� 靾� 鞛堨溂氅�, 須岇偓电� 鞚挫潣毳� 鞝滉赴頃� 靾� 鞛堨溂雮� 靹标车鞚� 氤挫灔霅橃电� 鞎婌姷雼堧嫟.

韱奠电� 歃夑皝鞝侅澑 雮橃姢雼� 瓯半灅 欷戨嫧 須臣电� 鞐嗢毵�, 鞙犽彊靹标臣 鞛愱笀 臁半嫭 鞙勴棙鞚� 歃濌皜頄堨潓鞚� 鞎岆雼堧嫟. 瓴届榿歆勳潃 MVLS毳� 氇媹韯半頃橁碃 "臧電ロ暅 鞓奠厴鞚� 韽夑皜頃� 瓴�"鞚措澕瓿� 氚濏様鞙茧倶 甑泊鞝侅澑 臁办箻电� 鞝滌嫓頃橃 鞎婌晿鞀惦媹雼�. 氙鸽灅 鞓堨浮 歆勳垹鞐愳劀电� 歆靻嶌爜鞚� 靻愳嫟, 鞛愲掣 頃勳殧靹�, 旮绊儉 靸侅灔 旮办 鞙勲皹 臧電レ劚鞚� 鞛皑 鞏戈笁頃橂┌ 欤检<霌れ棎瓴� 攵堩檿鞁れ劚鞚� 臧曥“頃╇媹雼�.

Dyadic International (NASDAQ:DYAI) a d茅pos茅 un rapport 8-K r茅v茅lant la r茅ception d鈥檜n avis de carence selon la r猫gle de cotation Nasdaq 5550(b)(2) pour ne pas avoir maintenu la valeur minimale de 35 millions de dollars en Market Value of Listed Securities (MVLS).

Le titre est rest茅 en dessous du seuil pendant 30 jours ouvrables cons茅cutifs, d茅clenchant une p茅riode de correction de 180 jours se terminant le 20 d茅cembre 2025. Pour retrouver la conformit茅, le MVLS de DYAI doit cl么turer 脿 ou au-dessus de 35 millions de dollars pendant au moins 10 jours de bourse cons茅cutifs avant la date limite. En cas d鈥櫭ヽhec, une d茅cision de radiation sera prise, que la soci茅t茅 pourra contester, bien que sans garantie de succ猫s.

尝鈥檃惫颈蝉 n鈥檃 pas d鈥檈ffet imm茅diat sur les 茅changes Nasdaq mais signale un risque accru de liquidit茅 et de financement. La direction indique qu鈥檈lle surveillera le MVLS et 芦 茅valuera les options disponibles 禄, sans pr茅ciser d鈥檃ctions sp茅cifiques. Les d茅clarations prospectives r茅it猫rent les pertes en cours, les besoins en capital et les violations potentielles d鈥檃utres normes de cotation, soulignant l鈥檌ncertitude pour les actionnaires.

Dyadic International (NASDAQ:DYAI) hat einen 8-K-Bericht eingereicht, in dem der Erhalt einer Nasdaq-Listing-Regel 5550(b)(2) M盲ngelmitteilung wegen Nichterf眉llung des Mindestwertes von 35 Millionen US-Dollar Market Value of Listed Securities (MVLS) offengelegt wird.

Die Aktie lag 30 aufeinanderfolgende Handelstage unter dem Schwellenwert, wodurch eine 180-t盲gige Nachfrist bis zum 20. Dezember 2025 in Kraft tritt. Um die Compliance wiederherzustellen, muss der MVLS von DYAI an mindestens 10 aufeinanderfolgenden Handelstagen vor Ablauf der Frist bei oder 眉ber 35 Millionen US-Dollar schlie脽en. Andernfalls wird eine Delisting-Entscheidung eingeleitet, gegen die das Unternehmen Berufung einlegen kann, wobei ein Erfolg nicht garantiert ist.

Die Mitteilung hat keine unmittelbaren Auswirkungen auf den Nasdaq-Handel, weist jedoch auf erh枚hte Risiken bei Liquidit盲t und Finanzierung hin. Das Management erkl盲rt, dass es den MVLS 眉berwachen und "verf眉gbare Optionen evaluieren" wird, nennt jedoch keine konkreten Ma脽nahmen. Prognostische Aussagen betonen weiterhin laufende Verluste, Kapitalbedarf und m枚gliche Verst枚脽e gegen andere Listing-Standards, was Unsicherheit f眉r die Aktion盲re unterstreicht.

false 0001213809 0001213809 2025-06-23 2025-06-23
 
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 

 
FORM 8-K
 

 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (date of earliest event reported): June 23, 2025
 

 
Dyadic International, Inc.
 
(Exact name of registrant as specified in its charter)
 

 
Delaware 000-55264 45-0486747
(State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification Number)
 
 
1044 North U.S. Highway One, Suite 201 Jupiter, FL 33477
(Address of principal executive offices and zip code)
 
(561) 743-8333
(Registrant’s telephone number, including area code)
 
N/A
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
Securities registered pursuant to Section 12(b) of the Act
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
DYAI
The Nasdaq Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
Item 3.01  Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
 
(a)
 
On June 23, 2025, Dyadic International, Inc. (the “Company”) received a deficiency notice (the “Notice”) from the Nasdaq Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days the Company’s securities have not maintained the minimum Market Value of Listed Securities (“MVLS”) of $35 million required by the continued listing requirements of Nasdaq Listing Rule 5550(b)(2). The Notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Capital Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has 180 calendar days, or until December 20, 2025 (the “Compliance Date”), to regain compliance with the minimum MVLS requirement by having the Company’s MVLS close at $35 million or more for a minimum of 10 consecutive business days before the Compliance Date (subject to the Staff’s discretion to extend this period under Nasdaq Listing Rule 5810(c)(3)(H)). If the Company does not regain compliance by the Compliance Date, the Staff will provide written notification that the Company’s common stock is subject to delisting. At that time, the Company may appeal the delisting determination to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq listing rules. However, there can be no assurance that, if the Company receives a delisting notice and appeals the delisting determination by Nasdaq to the panel, such appeal would be successful.
 
The Company intends to actively monitor the MVLS of its common stock between now and the Compliance Date and, as appropriate, plans to evaluate available options to resolve the deficiency and regain compliance with the minimum MVLS requirement.
 
Safe Harbor Regarding Forward-Looking Statements
 
This current report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, including those regarding the Company’s expectations, intentions, strategies, and beliefs pertaining to future events or future financial performance, including its plan to regain compliance with Nasdaq Listing Rule 5550(b)(2). Forward-looking statements involve many risks, uncertainties or other factors beyond the Company’s control. These factors include, but are not limited to, the following: (i) the Company’s history of net losses; (ii) the Company’s ability to maintain compliance with other Nasdaq continued listing standards and rules, including the minimum $1 bid price rule; (iii) the Company’s capital needs; and (iv) other factors impacting the Company’s business, results of operations and stock price, including market and regulatory acceptance of the Company’s microbial protein production platforms and other technologies, failure to commercialize the Company’s microbial protein production platforms or the Company’s other technologies, competition, including from alternative technologies, the results of nonclinical studies and clinical trials, changes in global economic and financial conditions, the Company’s reliance on information technology, the Company’s dependence on third parties, government regulations and environmental, social and governance issues, and intellectual property risks. For a more complete description of the risks that could cause the Company’s actual results to differ from the Company’s current expectations, please see the section entitled “Risk Factors” in the Company’s annual reports on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission (the “SEC”), as such factors may be updated from time to time in the Company’s periodic filings with the SEC, which are accessible on the SEC’s website and at www.dyadic.com. All forward-looking statements speak only as of the date made, and except as required by applicable law, the Company assumes no obligation to publicly update any such forward-looking statements for any reason after the date of this Current Report on Form 8-K to conform these statements to actual results or to changes in the Company’s expectations.
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: June 27, 2025 
 
 
 
Dyadic International, Inc.
 
 
 
 
 
 
By:
/s/ Ping Rawson
 
 
Name: 
Ping Rawson 
 
 
Title: 
Chief Financial Officer 
 
 
 

FAQ

Why did DYAI receive a Nasdaq deficiency notice?

Because its Market Value of Listed Securities fell below $35 million for 30 consecutive business days, violating Rule 5550(b)(2).

What is DYAI's deadline to regain compliance?

The company has until December 20, 2025鈥�180 calendar days from the notice date.

What must DYAI do to satisfy Nasdaq Rule 5550(b)(2)?

Maintain an MVLS of at least $35 million for 10 consecutive trading days before the deadline.

Does the notice immediately affect DYAI's Nasdaq listing?

No. The stock continues trading on Nasdaq Capital Market while the company works to regain compliance.

What happens if DYAI fails to regain compliance by the deadline?

Nasdaq will issue a delisting determination; DYAI could appeal, but success is not guaranteed.

Did DYAI outline a specific plan to resolve the deficiency?

Management stated it will monitor MVLS and evaluate options but did not disclose a detailed plan.
Dyadic Intl Inc Del

NASDAQ:DYAI

DYAI Rankings

DYAI Latest News

DYAI Latest SEC Filings

DYAI Stock Data

34.00M
20.97M
30.15%
17.3%
0.33%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
JUPITER